The Diagnostic Process: Scans and Tests for TGCV

Because Triglyceride Deposit Cardiomyovasculopathy (TGCV) is a metabolic disease happening deep inside your heart cells, it cannot be diagnosed with standard blood tests or a routine physical exam. Your doctors must use specialized imaging that looks specifically at how your heart metabolizes fat.

One of the most important things to understand is that serum triglycerides (the fat measured in a standard blood panel) and your body weight (BMI) are not used to diagnose TGCV ^[1]. You can have a perfectly healthy weight and normal blood fat levels while still having TGCV, because the problem is inside the heart cells themselves, not necessarily too much fat in your blood ^[2][3].

The Functional Test: BMIPP Scintigraphy

An important tool in diagnosing TGCV is a specialized nuclear medicine scan called Iodine-123-BMIPP scintigraphy ^[1]. This test uses a radioactive tracer that mimics the fatty acids your heart uses for fuel.

• How it works: You will typically receive two scans—an “early” scan shortly after the tracer is injected and a “delayed” scan several hours later ^[4][5].
• The Washout Rate: Doctors measure how much of the tracer has left (or “washed out”) of your heart between the two scans. This is called the myocardial washout rate (WR) ^[1].
• Interpretation: Under Japanese diagnostic criteria, a washout rate of less than 10% strongly supports a diagnosis of TGCV ^[1][4]. However, this is not a standalone diagnosis. A low washout must be interpreted carefully by an expert, as other factors—such as old heart attacks (myocardial infarction), severe ischemia, or another genetic condition called CD36 deficiency—can skew the results or mimic the findings ^[6][7].

Imaging Your Arteries: Diffuse vs. Focal

When doctors look at your coronary arteries using a Coronary CT or Angiography, they are usually looking for “focal” blockages—single spots where cholesterol has built up. In TGCV, the pattern is often very different:

• Diffuse, Concentric Narrowing: Instead of one or two blocked spots, the fat deposits in TGCV often cause the entire length of the blood vessel to narrow evenly ^[8][9].
• Imaging Findings: On an angiogram, your vessels might look generally “thin” or “small.” Advanced imaging like Intravascular Ultrasound (IVUS) might show specific low-echo structures around the outer layers of the artery wall ^[8].

Genetic Testing and Biopsy

To fully classify the disease, your doctor may use additional tests:

1. PNPLA2 Genetic Testing: This test looks for mutations in the PNPLA2 gene. To have confirmed Primary TGCV (P-TGCV), you must have compatible clinical symptoms and pathogenic mutations on both copies of the gene (biallelic variants) ^[1][10]. A single variant or a “variant of uncertain significance (VUS)” is not enough to confirm primary disease.
   • If genetic testing finds no mutations but you clearly have the functional disease phenotype, it is classified as Idiopathic TGCV (I-TGCV) ^[11]. However, remember that genetic tests are not perfect and can occasionally miss variants.
2. Endomyocardial Biopsy: In rare cases, a doctor may take a tiny sample of heart tissue. Under an electron microscope, this can show lipid vacuoles (tiny bubbles of fat) inside the heart cells, crowding the cellular structures ^[10][12]. Importantly, a biopsy is usually not required. It is an invasive procedure with procedural risks (including bleeding or rhythm issues) and is subject to sampling error. It is generally reserved for situations where the diagnosis is highly uncertain and the results would change your treatment plan.

Getting an accurate diagnosis is a team effort. Because TGCV can be confused with other conditions, an expert must synthesize your scans, symptoms, and genetics to confirm the disease safely.